Neuland Laboratories [NEULANDLAB] vs Alembic [APLLTD] Detailed Comparison

Neuland Laboratories

NSE

Alembic

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Neuland Laboratories wins in 12 metrics, Alembic wins in 8 metrics, with 0 ties. Neuland Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Neuland Laboratories	Alembic	Better
P/E Ratio (TTM)	67.61	34.25	Alembic
Price-to-Book Ratio	11.54	3.85	Alembic
Debt-to-Equity Ratio	10.31	24.23	Neuland Laboratories
PEG Ratio	-5.08	23.37	Neuland Laboratories
EV/EBITDA	54.01	21.38	Alembic
Profit Margin (TTM)	17.61%	8.74%	Neuland Laboratories
Operating Margin (TTM)	12.64%	11.48%	Neuland Laboratories
EBITDA Margin (TTM)	12.64%	11.48%	Neuland Laboratories
Return on Equity	18.53%	11.63%	Neuland Laboratories
Return on Assets (TTM)	8.26%	6.42%	Neuland Laboratories
Free Cash Flow (TTM)	$1.11B	$-4.76B	Neuland Laboratories
Dividend Yield	0.08%	1.15%	Alembic
1-Year Return	68.46%	-15.97%	Neuland Laboratories
Price-to-Sales Ratio (TTM)	11.92	2.99	Alembic
Enterprise Value	$175.16B	$211.51B	Alembic
EV/Revenue Ratio	11.86	3.17	Alembic
Gross Profit Margin (TTM)	47.62%	70.02%	Alembic
Revenue per Share (TTM)	$1,151	$339	Neuland Laboratories
Earnings per Share (Diluted)	$202.88	$29.68	Neuland Laboratories
Beta (Stock Volatility)	0.21	0.50	Neuland Laboratories

Complete Neuland Laboratories Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

You're looking at Neuland Laboratories and thinking "this could be a good investment." But how do you know for sure? What if there's a similar company that's actually growing faster, has less debt, or pays better dividends? That nagging "what if" feeling is exactly why smart investors always compare before they buy.

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

Is the stock price reasonable compared to how much money the company makes? Sometimes a $200 stock is actually cheaper than a $50 stock when you look at the bigger picture.

🏥 Which Company is Healthier

Does the company make good money and have manageable debt? You want to invest in companies that can weather tough times, not ones that might struggle if business gets rough.

📈 Which Has Been Growing Faster

Look at how the stocks have performed over the past few years. One might be having a great year while the other has been consistently growing for decades.

💵 Which Pays You Better

If you want your investments to pay you while you hold them, compare how much each company gives back to shareholders through dividends.

Here's How This Actually Helps You

🎯 The "Better Deal" Hunter

Sarah was ready to buy Neuland Laboratories at $150 per share. But when she compared it to Sun Pharmaceutical, she realized she could get similar growth potential for 30% less money. That comparison saved her $3,000 on a $10,000 investment.

🚀 The "Growth Spotter"

Mike almost bought Neuland Laboratories because he liked their products. Good thing he compared it with Divi's Laboratories first - turns out the competitor was growing twice as fast and had way less debt. Sometimes the less popular choice is the smarter choice.

💰 The "Income Seeker"

Lisa wanted dividend income for retirement. Neuland Laboratories looked good until she compared it with Alembic. The competitor was paying 40% higher dividends and had been increasing them every year for a decade. That's an extra $400 annually on a $10,000 investment.

What All These Numbers Actually Mean

Look, we know financial data can feel overwhelming. But here's the thing - you don't need a finance degree to understand what matters. We've organized everything into simple categories that answer the questions you actually care about:

📈 "How Has This Stock Performed?"

Stock price changes over the past few years
How bumpy the ride has been (some stocks swing wildly)
How it compares to the overall market

💰 "Is This Stock Expensive or Cheap?"

Price compared to company earnings (like a price-to-quality ratio)
What you're paying for each dollar of company assets
Overall company value vs. what it actually makes

🏢 "Is This Company in Good Shape?"

How much money they're bringing in and keeping
Their debt situation (too much debt is a red flag)
Whether they're generating actual cash or just paper profits

🎯 "What Am I Getting as an Investor?"

Dividend payments (your quarterly paycheck from owning the stock)
Who else is buying or selling (institutions vs. regular investors)
Whether the company is growing or shrinking

How to Actually Do This (Step by Step)

Don't overthink it. Here's exactly what to do:

Pick Another Stock to Compare

Use the search box above to find a similar company. Think competitors, companies in the same industry, or stocks you've heard about. Don't compare a tech startup to a utility company - that won't help much.

Look at the "Performance" Tab First

This shows you which stock has actually made more money for investors over time. If one is clearly winning year after year, that's worth paying attention to.

Check If the Price Makes Sense

Look at the "Valuation" tab. You want to see if you're paying a fair price for what you're getting. Sometimes the cheaper stock price isn't actually the better deal.

Trust Your Gut (But Verify with Data)

After looking at all the numbers, which company would you rather own a piece of? The data should support your intuition, not fight against it. If the numbers don't make sense to you, don't invest.

Ready to Make a Smarter Choice?

Use the search bar above to find a stock to compare with Neuland Laboratories. In just a few minutes, you'll know whether you've found a great investment or if there's something better out there.

💡 Quick Tip: The best comparisons are between companies you've actually heard of. If you can't explain what both companies do in one sentence, pick different stocks to compare.

🙏 The Reality Check

Look, we're just showing you the numbers - we're not telling you what to buy. Stock prices go up and down, and past performance doesn't guarantee future results. You know your financial situation better than anyone else, so make decisions that make sense for you. If you're investing money you can't afford to lose, talk to a financial advisor first.

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Neuland Laboratories vs Alembic Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Neuland Laboratories	-0.30%	-4.84%	12.67%	5.52%	0.14%	-3.45%
Alembic	-2.06%	-1.69%	7.56%	15.67%	7.22%	-2.91%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Neuland Laboratories	68.46%	984.50%	1,706.80%	2,763.06%	17,562.08%	16,416.85%
Alembic	-15.97%	45.60%	3.76%	43.94%	2,098.06%	2,098.06%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Neuland Laboratories (NEULANDLAB): View Full Stock Overview

Alembic (APLLTD): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Neuland Laboratories vs Alembic

Metric	NEULANDLAB	APLLTD
Market Information
Market Cap i	₹175.99B	₹199.79B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	257,444	141,282
90 Day Avg. Volume i	121,720	671,137
Last Close	₹13,760.00	₹997.50
52 Week Range	₹8,270.00 - ₹18,100.00	₹725.20 - ₹1,303.90
% from 52W High	-23.98%	-23.50%
All-Time High	₹18,100.00 (Dec 02, 2024)	₹1,303.90 (Oct 07, 2024)
% from All-Time High	-23.98%	-23.50%
Growth Metrics
Quarterly Revenue Growth	-0.15%	0.17%
Quarterly Earnings Growth	-0.59%	-0.12%
Financial Health
Profit Margin (TTM) i	0.18%	0.09%
Operating Margin (TTM) i	0.13%	0.11%
Return on Equity (TTM) i	0.19%	0.12%
Debt to Equity (MRQ) i	10.31	24.23
Cash & Liquidity
Book Value per Share (MRQ)	₹1,188.48	₹264.09
Cash per Share (MRQ)	₹186.76	₹4.25
Operating Cash Flow (TTM) i	₹3.17B	₹879.70M
Levered Free Cash Flow (TTM) i	₹-137,987,008	₹-7,272,162,304
Dividends
Last 12-Month Dividend Yield i	0.08%	1.15%
Last 12-Month Dividend i	₹12.00	₹11.00

Valuation & Enterprise Metrics Analysis: Neuland Laboratories vs Alembic

Metric	NEULANDLAB	APLLTD
Price Ratios
P/E Ratio (TTM) i	67.61	34.25
Forward P/E i	35.32	23.37
PEG Ratio i	-5.08	23.37
Price to Sales (TTM) i	11.92	2.99
Price to Book (MRQ) i	11.54	3.85
Market Capitalization
Market Capitalization i	₹175.99B	₹199.79B
Enterprise Value i	₹175.16B	₹211.51B
Enterprise Value Metrics
Enterprise to Revenue i	11.86	3.17
Enterprise to EBITDA i	54.01	21.38
Risk & Other Metrics
Beta i	0.21	0.50
Book Value per Share (MRQ) i	₹1,188.48	₹264.09

Financial Statements Comparison: Neuland Laboratories vs Alembic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	NEULANDLAB	APLLTD
Revenue/Sales i	₹3.28B	₹17.70B
Cost of Goods Sold i	₹1.72B	₹5.31B
Gross Profit i	₹1.56B	₹12.39B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹341.82M	₹2.03B
EBITDA i	₹585.38M	₹2.85B
Pre-Tax Income i	₹393.00M	₹1.92B
Income Tax i	₹114.94M	₹353.10M
Net Income (Profit) i	₹278.06M	₹1.57B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	NEULANDLAB	APLLTD
Cash & Equivalents i	₹1.32B	₹834.80M
Total Current Assets i	₹11.39B	₹40.88B
Total Current Liabilities i	₹4.66B	₹23.93B
Long-Term Debt i	₹1.09B	₹467.70M
Total Shareholders Equity i	₹15.25B	₹51.90B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹6.74B	₹25.24B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	NEULANDLAB	APLLTD
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	NEULANDLAB	APLLTD
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	257,444	141,282
Average Daily Volume (90 Day) i	121,720	671,137
Shares Outstanding i	12.83M	196.56M
Float Shares i	7.19M	57.33M
% Held by Insiders i	0.38%	0.70%
% Held by Institutions i	0.25%	0.17%

Dividend Analysis & Yield Comparison: Neuland Laboratories vs Alembic

Metric	NEULANDLAB	APLLTD
Last 12-Month Dividend i	₹12.00	₹11.00
Last 12-Month Dividend Yield i	0.08%	1.15%
3-Year Avg Annual Dividend i	₹12.00	₹9.67
3-Year Avg Dividend Yield i	0.20%	1.19%
3-Year Total Dividends i	₹36.00	₹29.00
Ex-Dividend Date	Jul 18, 2025	Jul 15, 2024